Benesch, M <br/><br/>
Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.  [electronic resource] 

 -  Bone marrow transplantation  Dec 2003 
 - 1071-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704277  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amifostine--administration & dosage<br/>Busulfan--administration & dosage<br/>Cause of Death<br/>Cytoprotection--drug effects<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Middle Aged<br/>Myeloablative Agonists--administration & dosage<br/>Myelodysplastic Syndromes--complications<br/>Pilot Projects<br/>Siblings<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Whole-Body Irradiation